Outlook Therapeutics (OTLK) FCF Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) FCF Margin (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.43 Mn |
| Sep 30, 2019 | 155,110.00 |
| Jun 30, 2019 | -60,310.00 |
| Mar 31, 2019 | -7,469.00 |
| Dec 31, 2018 | 27,626.00 |
| Sep 30, 2018 | -12,354.00 |
| Jun 30, 2018 | -12,815.00 |
| Mar 31, 2018 | 26,326.00 |
| Dec 31, 2017 | -125,615.00 |
| Sep 30, 2017 | 183,333.00 |
| Jun 30, 2017 | -50,667.00 |
| Mar 31, 2017 | 64,284.00 |
| Dec 31, 2016 | 18,583.00 |
| Sep 30, 2016 | 117,108.00 |
| Jun 30, 2016 | -262,818.00 |
| Mar 31, 2016 | 53,928.00 |
| Dec 31, 2015 | 164,714.00 |
| Sep 30, 2015 | -184,663.00 |